
M. Franco G. Salvoza
Examiner (ID: 7294, Phone: (571)272-4468 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1672, 1648, 1671 |
| Total Applications | 794 |
| Issued Applications | 451 |
| Pending Applications | 120 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6990948
[patent_doc_number] => 20050089985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Rescue of canine distemper virus from cdna'
[patent_app_type] => utility
[patent_app_number] => 10/312052
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21330
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312052 | Rescue of canine distemper virus from cdna | Jun 21, 2001 | Abandoned |
Array
(
[id] => 6715783
[patent_doc_number] => 20030027131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Method for expressing and purifying proteins using budded baculovirus'
[patent_app_type] => new
[patent_app_number] => 09/884481
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8125
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09884481
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/884481 | Method for expressing and purifying proteins using budded baculovirus | Jun 19, 2001 | Issued |
Array
(
[id] => 6925797
[patent_doc_number] => 20050239052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Cloning of rhadinovirus genome and methods for its use'
[patent_app_type] => utility
[patent_app_number] => 10/276524
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 35193
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239052.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276524
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276524 | Cloning of rhadinovirus genome and methods for its use | May 16, 2001 | Abandoned |
Array
(
[id] => 6797498
[patent_doc_number] => 20030176372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Anti-virus agent'
[patent_app_type] => new
[patent_app_number] => 09/848269
[patent_app_country] => US
[patent_app_date] => 2001-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3068
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176372.pdf
[firstpage_image] =>[orig_patent_app_number] => 09848269
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/848269 | Anti-virus agent | May 3, 2001 | Abandoned |
Array
(
[id] => 768220
[patent_doc_number] => 07005131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-28
[patent_title] => 'Protective antigen of Epstein Barr Virus'
[patent_app_type] => utility
[patent_app_number] => 10/049316
[patent_app_country] => US
[patent_app_date] => 2000-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 50
[patent_no_of_words] => 21284
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10049316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/049316 | Protective antigen of Epstein Barr Virus | Aug 9, 2000 | Issued |
Array
(
[id] => 428392
[patent_doc_number] => 07267825
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-09-11
[patent_title] => 'Parvovirus vectors and their use'
[patent_app_type] => utility
[patent_app_number] => 09/807579
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3277
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/267/07267825.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807579
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807579 | Parvovirus vectors and their use | Oct 13, 1999 | Issued |
Array
(
[id] => 727407
[patent_doc_number] => 07041293
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-09
[patent_title] => 'HIV env antibodies'
[patent_app_type] => utility
[patent_app_number] => 09/103262
[patent_app_country] => US
[patent_app_date] => 1998-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 23828
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041293.pdf
[firstpage_image] =>[orig_patent_app_number] => 09103262
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/103262 | HIV env antibodies | Jun 22, 1998 | Issued |